|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$71,024.99 |
2.17% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$69,130.53 |
2.12% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$69,348.72 |
2.12% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$68,982.10 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,795.54 |
2.11% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$69,093.79 |
2.11% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$68,859.00 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$68,654.31 |
2.10% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$68,745.60 |
2.10% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,394.45 |
2.09% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$68,443.60 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$68,411.60 |
2.09% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$67,903.11 |
2.08% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$67,813.76 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,053.26 |
2.08% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$68,109.48 |
2.08% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$67,630.32 |
2.07% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,736.48 |
2.07% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$67,491.74 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,802.16 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$67,436.23 |
2.06% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$67,428.76 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$67,260.69 |
2.06% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$67,341.05 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,319.94 |
2.06% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,248.09 |
2.06% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$67,146.73 |
2.05% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$67,118.70 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$66,996.20 |
2.05% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,656.25 |
2.04% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$66,566.03 |
2.04% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,631.47 |
2.04% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$66,634.40 |
2.04% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$66,388.40 |
2.03% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$66,350.31 |
2.03% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$66,011.19 |
2.02% |
| Steris Plc |
STE |
G8473T100 |
298 |
$66,001.04 |
2.02% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$65,654.28 |
2.01% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$64,886.90 |
1.99% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$64,993.15 |
1.99% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$64,646.12 |
1.98% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,712.00 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$64,851.08 |
1.98% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$64,527.42 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$63,087.50 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$60,997.60 |
1.87% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$59,371.99 |
1.82% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$54,111.49 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,535.49 |
1.36% |
| US Dollar |
$USD |
|
24,365 |
$24,365.40 |
0.75% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|